Analyzing the Development of EGFRvii x MUC1 Bispecific ADC & Its Strategy in Improving Tumor Penetration

  • Introducing EGFRviii and MUC1
  • Exploring the dual combination of EGFRviii x MUC1
  • Discussing better enrichment of ADC into the TME in the presence of vessel normalizer, PMC-403